JYNT in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with JYNT today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
The Joint Corp. runs a U.S. chiropractic clinic network under THE JOINT CHIROPRACTIC brand, with most clinics operated by franchisees. Patients walk in without appointments and pay directly for adjustments, memberships or treatment packages. Clinics do not accept insurance or provide Medicare-covered services.
Franchisees pay the company for access to its brand and operating support. Royalties based on clinic sales provide most revenue; franchisees also pay initial franchise fees and ongoing marketing and software fees. The company still owns or manages some clinics but is selling them as it works toward becoming solely a franchisor. Its income therefore depends heavily on franchisees attracting patients, operating successfully and paying their fees.
State rules limit how the company can participate in clinical care. Where corporate practice restrictions apply, licensed chiropractors own separate professional entities that provide treatment and control clinical decisions. The Joint Corp. and franchisees not owned by chiropractors provide nonclinical management services instead.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
The Joint Corp.’s results hinge on chiropractic visits paid for out of pocket, membership retention and franchise clinic growth—not the banking or technology-licensing businesses supplied here.
The Joint Corp. earningsThis company
The Joint Corp. is shifting toward franchising, and this report will show whether franchise-clinic sales are lifting royalties enough to support the business as it sells company-operated clinics.
Read royalty revenue alongside franchised-clinic count and comparable sales: royalties are tied to franchisees’ gross sales. Rising royalties with more clinics and improving comparable sales would show franchisees are expanding the sales base and strengthening recurring income; weak royalties with stalled clinic growth or comparable sales would show the network is not yet generating enough to offset the business JOINT is selling.